BioLife Solutions (BLFS) Misses Q2 EPS by 2c

August 11, 2016 4:39 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $2 million versus the consensus estimate of $2.01 million.

BioLife Solutions reaffirmed FY2016 guidance.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment